Abstract
Short stature is one of the main features of Turner syndrome. Today, most patients are treated with growth hormone (GH) to improve adult height. We have reviewed the literature reporting adult height in patients with Turner syndrome treated with GH alone or in combination with oxandrolone. The reported adult heights as well as the height gain over projected or predicted height are still preliminary and vary considerably among studies. There is some evidence that the age of onset of therapy, dose of GH, duration of GH therapy, target height, time of estrogen substitution, or concurrent treatment with oxandrolone affect adult height. The reported height gains over projected height range from −0.20 to +16.0 cm (median: 5.1 cm) in patients treated with GH and from +0.68 cm to +10.3 (median: 6.40 cm) in patients treated with GH and oxandrolone. Thus, the presently available data are extremely varied and need further detailed analysis after all ongoing clinical trials have published the final results of all patients included in the study.
Similar content being viewed by others
References
Butenandt, O. (1980). Klin. Wochenschr. 58, 99–101.
Tanner, J. M., Whitehouse, R. H., Hughes, P. C. R., and Vince, F. P. (1971). Arch. Dis. Child. 46, 745–782.
Joss, E. E. and Zuppinger, K. A. (1984). Acta Paediatr. Scand. 73, 174–179.
Naeraa, R. W., Nielsen, J., Pedersen, I. J., and Sorensen, K. (1990), Acta Paediatr. Scand. 79, 784–789.
Moore, D. C., Tattoni, D. S., Ruvalcaba, R. H. A., Limbeck, G. A., and Kelley, V. C. (1977). J. Pediatr. 90, 462–466.
Urban, M. D., Lee, P. A., Dorst, J. P., Plotnick, L. P., and Migeon, C. J. (1979). J. Pediatr. 94, 823–827.
Lev-Ran. (1977). Am. J. Dis. Child. 131, 648,649.
Attanasio, A., James, D., Reinhardt, R., and Rekers-Momberg, L. (1995). Horm Res. 43, 147–149.
Betts, P. R., Butler, G. E., Donaldson, M. D. C., Dunger, D. B., Johnston, D. I., Kelnar, C. H. J., Kirk, J., Price, D. A., Wilton, P., and the UK KIGS Executive Group on behalf of the participating centres. (1999). Arch. Dis. Child. 80, 221–225.
Broeck, van den, J., Massa, G. G., Attanasio, A., Martrange, A., Chaussain, J.-L., Price, D. A., Aaarskog, D., Wit, J.-M., and the European Study Group. (1995). J. Pediatr. 127, 729–735.
Cacciari, E., Mazzanti, L., and the Italian Study Group for Turner Syndrome. (1998). J. Clin. Endocrinol. Metab. 84, 4510–4515.
Canadian growth hormone advisory committee. (1998). Horm. Res. 50(Suppl. 3), 25.
Carel, J. D., Mathivon, L., Gendrel, C., Ducret, J. P., and Chaussain, J.-L. (1998). J. Clin. Endocrinol. Metab. 83, 1462–1466.
Chernausek, S. D., Attie, K. M., Cara, J. F., Rosenfeld, R. G., Frane, J., and The Geneentech. Inc., Collaborative Study Group. (2000). J. Clin. Endocrinol. Metab. 85, 2439–2445.
Chu, C. E., Paterson, W. F., Kelnar, C. J. H., Smail, P. J., Greene, S. A., and Donaldson, M. D. C. (1997). Acta Paediatr. 86, 160–164.
Dacou-Voutetakis, C., Karavanaki-Karanassiou, K., Petrou, V., Georgopoulos, N., Maniati-Christidi, M., and Mavrou, A. (1998). Pediatrics 101, 663–668.
Hauessler, G., Schmitt, K., Blümel, P., Plöchl, E., Waldhör, T. H., and Frisch, H. (1996). Acta Paediatr. 85, 1408–1414.
Hochberg, Z. and Zadik, Z. (1998). Eur. J. Endocrinol. 141, 218–224.
Massa, G., Otten, B. J., de Muinck Keizer-Schrama, S. M. P. F., Delamarre van de Waal, H. A., Jansen, M., Vulsma, T., Oostdijk, W., Waelkens, J. J., and Wit, J. M., for the Dutch Growth Hormone Working Group. (1995). Horm. Res. 43, 144–146.
Nilsson, K. O., Albertsson-Wikland, K., Alm, J., et al. (1996). J. Clin. Endocrinol. Metab. 81, 635–640.
Plotnick, L., Attie, K., Blethen, S., and Spy, J. P. (1998). Pediatrics 102, 479–481.
Rosenfeld, R., Attie, K. M., Frane, J., Brasel, J. A., Burstein, S., Cara, J. F., Chernausek, S., Gotlin, R. W., Kuntze, J., Lippe, B. M., Mahoney, C. P., Moore, W. V., Saenger, P., and Johnason, A. J. (1998). J. Pediatr. 132, 319–324.
Sas, T. C. J., de Muinck Keizer-Schrama, S. M. P. F., and Stijnen, T., et al. (1999). J. Clin. Endocrinol. Metab. 84, 4607–4612.
Sas, T. C. J., de Muinck Keizer-Schrama, S. M. P. F., and Stijnen, T. (1999). Arch. Dis. Child. 80, 36–41.
Sas, T. C. J., Gerver, W.-J. M., de Bruin, R., Stijnen, T., de Muinck Keizer-Schrama, S. M. P. F., Cole, T. J., van Teunenbroek, A., and Drop, S. L. S. (1999). J. Clin. Endocrinol. Metab. 84, 4622–4628.
Stahnke, N., Keller, E., and Landy, H. J. Ped. Endo. Metab., to be published.
Taback, S. P., Collu, R., Deal, C. L., Guyda, H. J., Salisbury, S., Dean, H. J., and van Vliet, G. (1996). Lancet 348, 25–27.
Takano, K., Ogawa, M., Tanaka, T., Tachibana, K., Fujita, K., Hizuka, N., and The Members of the Committee for the Treatment of Turner's Syndrome. (1997). Eur. J. Endocrinol. 137, 138–145.
Guyda, H. (1999). J. Clin. Endocrinol. Metab. 84, 4307–4316.
Raiti, S., Moore, W. V., van Vliet, G., and Kaplan, S. L. (1986). J. Pediatr. 109, 944–949.
Buchanan, C. R., Law, C. M., and Milner, R. D. G. (1987). Arch. Dis. Child. 62, 912–916.
Rongen-Westerlaken, C., Wit, J. M., de Muinck Keizer-Schrama, S. M. P. F., et al. (1992). Eur. J. Pediatr. 151, 477–481.
Rosenfeld, R., Frane, J., Attie, K. M., Brasel, J. A., Burstein, S., Cara, J. F., Chernausek, S., Gotlin, R. W., Kuntze, J., Lippe, B. M., Mahoney, C. P., Moore, W. V., Saenger, P., and Johnason, A. J. (1992), J. Pediatr. 121, 49–55.
Naeraa, R. W., Nielsen, J., and Kastrup, K. W. (1994). Eur. J. Pediatr. 153, 72–77.
Ross, J. L. and Cutler, G. B. In: Turner Syndrome. Rosenfeld, R. G. and Grumbach, M. M. (eds.) Marcel Dekker: New York.
Vanderschueren-Lodeweyckx, M., Massa, G., Maes, M., Craen, M., van Vliet, G., Heinrichs, C., and Malvaux, P. (1990). J. Clin. Endocrinol. Metab. 70, 122–126.
Donaldson, M. D. C. (1997). Horm. Res. 48(Suppl. 5), 35–44.
Ranke, M. B., Pfluger, H., Rosendahl, W., Stubbe, P., Enders, H., Bierich, J. R., and Majewski, F. (1983). Eur. J. Pediatr. 141, 81–88.
Lyon, A. J., Preece, M. A., Grant, D. B. (1985). Arch. Dis. Child. 60, 932–935.
Prader, A., Largo, R. H., Molinari, L., and Issler, C. (1989). Helv. Paediatr. Acta 52(Suppl.), 1–125.
Fredriks, A. M., van Buuren, S., Burgmeijer, R. J. F., Meulmeester, J. F., Beuker, R. J., Brugman, E., Roede, M. J., Verloove-Vanhorick, S. P., and Wit, J.-M. (2000). Pediatr. Res. 47, 316–323.
Rochiccioli, P., David, M., and Malpuech, G., et al. (1994). Acta Paediatr. 83, 305–308.
Rongen-Westerlaken, C., Corel, L., van den Broeck, J., Massa, G., Karlberg, J., Albertsson-Wikland, K., Naeraa, R. W., and Wit, J. M. (1997). Acta Paediatr. 86, 937–942.
Brook, C. G. D., Mürset, G., Zachmann, M., and Prader, A. (1974). Arch. Dis. Child. 49, 789–795.
Brämswig, J. H. (1997). Eur. J. Endocrinol. 137, 446–447.
Teunenbroek, A., Stijnen, T., and Otten, B. (1996), Acta Paediatr. 85, 413–420.
Bayley, N. and Pinneau, S. R. (1952). J. Pediatr. 41, 423–441.
Roede, M. J. and Wieringen, J. C. (1985). Tijdschr. Soc. Gezondh. 63(Suppl.), 1–34.
Tanner, J. M. (1962). Growth at adolescence. 2nd ed., Blackwell: Oxford.
Bernasconi, S., Larizza, D., Benso, L., Volta, C., Vanelli, S., and Milani, S., on behalf of the Italian Study Group for Turner Syndrome. (1994). Acta Paediatr. 83, 292–298.
Karlberg, J., Albertsson-Wikland, K., Naeraa, R. W., Rongen-Westerlaken, C., and Wit, J. M., in collaboration with the Swedish and Dutch Study Group for GH Treatment. In: Basic and clinical approach to Turner syndrome. Hibi, I. and Takano, K., (eds). Excerpta Medica: Amsterdam.
Haeussler, G., Schemper, M., Frisch, H., Blümel, P., Schmitt, K., and Plöchl, E. (1992). Eur. J. Pediatr. 151, 283–287.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bramswig, J.H. Long-term results of growth hormone therapy in turner syndrome. Endocr 15, 5–13 (2001). https://doi.org/10.1385/ENDO:15:1:005
Issue Date:
DOI: https://doi.org/10.1385/ENDO:15:1:005